To further confirm the UBXN2A‐dependent reduction in mot‐2 proteins in cancer cells, we used a Tet‐on system to induce the expression of UBXN2A in HCT‐116 colon cancer cells. This evidence concerns the gene HSPA9 and malignant colon neoplasm.